Edwards Lifesciences Corporation Other Non-Current Liabilities
Edwards Lifesciences Corporation (EW) had Other Non-Current Liabilities of $381.80 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-04
- 2026-06-30: Other Liabilities, Noncurrent $381.80M.
- 2026-03-31: Other Liabilities, Noncurrent $350.70M.
- 2025-12-31: Other Liabilities, Noncurrent $362.30M.
- 2025-09-30: Other Liabilities, Noncurrent $362.60M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $381.80M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $350.70M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $362.30M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $362.60M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $379.20M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $357.60M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $373.30M 10-K · filed 2026-02-25 | $357.50M 10-K · filed 2025-02-28 |
| 2024-09-30 | $322.60M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $257.10M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $266.50M 10-Q · filed 2024-04-29 | |
| 2023-12-31 | $251.30M 10-K · filed 2025-02-28 | $264.30M 10-K · filed 2024-02-12 |
| 2023-09-30 | $240.30M 10-Q · filed 2023-10-27 | |
| 2023-06-30 | $242.70M 10-Q · filed 2023-07-28 | |
| 2023-03-31 | $260.10M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $217.50M 10-K · filed 2024-02-12 | |
| 2022-09-30 | $221.10M 10-Q · filed 2022-10-28 | |
| 2022-06-30 | $222.20M 10-Q · filed 2022-07-29 | |
| 2022-03-31 | $259.70M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $267.30M 10-K · filed 2023-02-13 | |
| 2021-09-30 | $275.50M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $268.40M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $250.80M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $252.40M 10-K · filed 2022-02-14 | |
| 2020-09-30 | $484.00M 10-Q · filed 2020-10-26 | |
| 2020-06-30 | $465.70M 10-Q · filed 2020-07-27 | |
| 2020-03-31 | $192.30M 10-Q · filed 2020-04-28 | |
| 2019-12-31 | $203.30M 10-K · filed 2021-02-12 | |
| 2019-09-30 | $159.90M 10-Q · filed 2019-10-25 | |
| 2019-06-30 | $162.20M 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $156.70M 10-Q · filed 2019-04-26 | |
| 2018-12-31 | $150.00M 10-K · filed 2020-02-14 | |
| 2018-09-30 | $285.10M 10-Q · filed 2018-10-26 | |
| 2018-06-30 | $282.50M 10-Q · filed 2018-07-27 | |
| 2018-03-31 | $321.80M 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $147.10M 10-K · filed 2019-02-15 | |
| 2017-09-30 | $416.20M 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $420.90M 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $409.40M 10-Q · filed 2017-04-28 | |
| 2016-12-31 | $115.30M 10-K · filed 2018-02-16 | $306.40M 10-K · filed 2017-02-17 |
| 2016-09-30 | $513.80M 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $499.50M 10-Q · filed 2016-07-29 | |
| 2016-03-31 | $494.00M 10-Q · filed 2016-04-29 | |
| 2015-12-31 | $285.40M 10-K · filed 2017-02-17 | |
| 2015-09-30 | $317.80M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $274.20M 10-Q · filed 2015-07-29 | |
| 2015-03-31 | $266.50M 10-Q · filed 2015-04-29 | |
| 2014-12-31 | $112.60M 10-K · filed 2016-02-19 | $105.60M 10-K · filed 2015-02-20 |
| 2014-09-30 | $282.40M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $273.20M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $229.30M 10-Q · filed 2014-05-02 | |
| 2013-12-31 | $100.40M 10-K · filed 2015-02-20 | |
| 2013-09-30 | $226.00M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $218.40M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $211.50M 10-Q · filed 2013-05-06 | |
| 2012-12-31 | $94.80M 10-K · filed 2014-02-28 | $205.50M 10-K · filed 2013-02-28 |
| 2012-09-30 | $185.50M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $171.10M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $169.30M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $157.00M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $151.30M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $129.10M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $128.10M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $121.20M 10-K · filed 2012-02-27 | |
| 2010-09-30 | $109.70M 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $98.90M 10-Q · filed 2010-08-06 | |
| 2009-12-31 | $76.80M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |